Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors.

The Journal of pediatrics - 1 Jan 2008

Krull Kevin R, Brouwers Pim, Jain Neelam, Zhang Linna, Bomgaars Lisa, Dreyer ZoAnn, Mahoney Donald, Bottomley Sarah, Okcu M Fatih

Abstract excerpt

OBJECTIVE: To test the hypothesis that 5,10-methylenetetrahydroreductase (MTHFR) polymorphisms can partially explain the individual variation in developing attention-deficit/hyperactivity disorder (ADHD) after acute lymphoblastic leukemia (ALL) therapy. STUDY DESIGN: Parents of 48 survivors of childhood ALL completed a clinical diagnostic process to identify subtypes of ADHD. Genotyping was performed with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Attention Deficit Disorder with Hyperactivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Folic Acid Antagonists

Share to Methotrexate

Share to Parents

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Surveys and Questionnaires

Share to Survivors

Source

Identifiers

PMID: 18154909
DOI: 10.1016/j.jpeds.2007.05.047

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors.PMID 18154909Read ↗

Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.Semantic proximity Read ↗

Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Folate pathway gene polymorphisms, maternal folic acid use, and risk of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute lymphoblastic leukemia in children.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemiaSemantic proximity Read ↗

Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia.Semantic proximity Read ↗

Altered methyltetrahydrofolate reductase gene polymorphism in mothers of children with attention deficit and hyperactivity disorder.Semantic proximity Read ↗

Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Involvement of MTHFR and TPMT genes in susceptibility to childhood acute lymphoblastic leukemia (ALL) in Mexicans.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians.Semantic proximity Read ↗

A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.